You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

 

Online download statistics by month:

Online download statistics by month: March 2020 to October 2024

AbstractFullPdf
Mar 2020191191146
Apr 2020304304120
May 202023723767
Jun 202010710727
Jul 2020828231
Aug 2020939345
Sep 2020999949
Oct 2020989845
Nov 202010510725
Dec 2020737327
Jan 2021909034
Feb 2021767730
Mar 202111311344
Apr 2021858549
May 2021424219
Jun 2021696933
Jul 2021676716
Aug 2021616142
Sep 2021535339
Oct 2021494951
Nov 2021474728
Dec 2021929424
Jan 202211711831
Feb 202211111127
Mar 202212212330
Apr 202210210316
May 202212512531
Jun 202211912034
Jul 202211411422
Aug 202215415434
Sep 202211411665
Oct 202212812832
Nov 202210410628
Dec 202210010523
Jan 202311411726
Feb 202313113637
Mar 202310711025
Apr 202310210534
May 202311411422
Jun 202313813824
Jul 202315715742
Aug 202314714738
Sep 202313913944
Oct 202313713733
Nov 202312312422
Dec 202313313313
Jan 2024767726
Feb 2024434414
Mar 2024535360
Apr 2024767633
May 2024525227
Jun 2024585820
Jul 202411011430
Aug 2024393924
Sep 2024444523
Oct 20245757155
Total579358332136